Format

Send to

Choose Destination
Leukemia. 2020 Jan 14. doi: 10.1038/s41375-020-0707-2. [Epub ahead of print]

Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1.

Author information

1
Department of Medicine, Hematology/Oncology, Goethe-University, Frankfurt, Germany. h.pfeifer@em.uni-frankfurt.de.
2
Pediatric Clinic, University of Milan Bicocca, San Gerardo Hospital, Monza, Italy.
3
Department of Immunology, Erasmus MC, University, Medical Center Rotterdam, Rotterdam, The Netherlands.
4
Hematology Laboratory and EA3518, University Hospital Saint-Louis, University Paris Diderot, Paris, France.
5
Kinderspital Zurich, Onkologie Diagnostik Labor, Zurich, Switzerland.
6
Hematology and Bone Marrow Transplant Unit, ASST-Papa Giovanni XXIII, Bergamo, Italy.
7
Regional Genetics Laboratory, Birmingham Women's NHS Foundation Trust, Birmingham, UK.
8
Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
9
Division of Hematology and Hemotherapy, Medical School, University of Sao Paulo, Sao Paulo, Brazil.
10
Department of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
11
Department of Genetic Biochemistry, Hopital Robert Debre, Paris, France.
12
Department of Hematology, Laboratory of Molecular Biology, University La Sapienza, Roma, Italy.
13
Institute for Genomic Medicine, Nationwide Children's Hospital and the Ohio State University, Columbus, OH, USA.
14
Imperial Molecular Pathology, Centre for Hematology, Imperial College London, London, UK.
15
Laboratory of Molecular Biology and UMR5239, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Benite, Lyon, France.
16
Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
17
Division of Pediatric Hematology/Oncology, Department of Pediatrics, National University Hospital, Singapore, Singapore.
18
Department of Internal Medicine-Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
19
Department of Hematology, University Hospital of Salamanca (IBSAL) & Cancer Research Centre-IBMCC, (Salamanca University-CSIC), Salamanca, Spain.
20
Department of Experimental Immunhematology/Immuncytology, Sanquin Diagnostics, Amsterdam, The Netherlands.
21
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
22
TYKSLAB, Laboratory of Molecular Genetics, Turku University Hospital, Turku, Finland.
23
Abteilung fur Hamatologie und internistische Onkologie, Universitat Leipzig, Leipzig, Germany.
24
Childrens Cancer Research Institute, Labdia Labordiagnostik and Medical University, Vienna, Austria.
25
III. Medizinische Klinik, Medizinische Fakultat Mannheim der Universitat Heidelberg, Mannheim, Germany.
26
Azienda Ospedaliera Universitaria Federico II di Napoli Universita, Naples, Italy.
27
Department of Hematology, Royal Free Campus, University College London, London, United Kingdom.
28
Department of Pediatric Hematology and Oncology, University Hospital, Justus Liebig University Giessen, Giessen, Germany.
29
Hematology Department, Jagiellonain University Krakow, Krakow, Poland.
30
MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, Munich, Germany.
31
Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
32
Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
33
Center for Human Genetics, University Hospital Leuven and KU Leuven, Leuven, Belgium.
34
CLIP, Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University and UH Motol, Prague, Czech Republic.
35
Department of Medicine, Hematology/Oncology, Goethe-University, Frankfurt, Germany.
36
Institut fur Biostatistik und Mathematische Modellierung, Goethe Universitat, Frankfurt, Germany.
37
Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, Leiden, The Netherlands.
38
School of Medicine, Division of Cancer and Hematology, Cardiff University, Cardiff, UK.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

PMID:
31937894
DOI:
10.1038/s41375-020-0707-2

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center